NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury...
Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury...
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI...
-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a...
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global artificial intelligence (AI)...
PRINCETON, N.J., Nov. 13, 2024 /PRNewswire/ -- EDETEK, Inc., a leading global provider of specialized software and services for the...
- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial --...
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3%...
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology company based out of New York and Bangalore,...
SANTA FE, N.M., Nov. 13, 2024 /PRNewswire/ -- Vitazi.ai, a leader in the field of oculomics, is transforming healthcare with an...
Subtle's Latest Solutions and Partnerships Set New Benchmarks for AI-powered Acceleration and Image Quality MENLO PARK, Calif., Nov. 13, 2024...
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov....
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp....
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately...
SANTA CLARA, CA / ACCESSWIRE / November 13, 2024 / The WiTT Group™, Inc. a Digital Health and FinTech company...
Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE...
CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited...
Novel Hyperbaric Oxygen Therapy Shows Promise in Treating Combat-Related PTSD in Veterans, lessening symptoms with lifechanging outcomesORLANDO, Fla., Nov. 13,...
Previously COO at leading health technology company Ada Health, Lemarié is an award-winning strategist whose expertise will further myTomorrows' mission...
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...